5 NYSE Healthcare Stocks With The Highest ROI

Below are the top NYSE stocks in the healthcare sector in terms of return on investment. The trailing-twelve-month return on investment at Novo Nordisk A/S (ADR) NVO is 65.50 percent. Novo Nordisk's revenue for the same period is $14.00 billion. The trailing-twelve-month return on investment at InVitae Corp NVTA is 59.20 percent. InVitae's revenue for the same period is $2.70 million. The trailing-twelve-month return on investment at USANA Health Sciences, Inc. USNA is 33.50 percent. USANA Health Sciences' revenue for the same period is $827.40 million. The trailing-twelve-month return on investment at Taro Pharmaceutical Industries Ltd. TARO is 30.40 percent. Taro Pharmaceutical's revenue for the same period is $862.90 million. The trailing-twelve-month return on investment at Edwards Lifesciences Corp EW is 29.10 percent. Edwards Lifesciences' revenue for the same period is $2.39 billion.